請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30673完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 吳淑瓊(Shwu-Chong Wu) | |
| dc.contributor.author | Yi-Ting Hao | en |
| dc.contributor.author | 郝怡婷 | zh_TW |
| dc.date.accessioned | 2021-06-13T02:11:55Z | - |
| dc.date.available | 2007-07-10 | |
| dc.date.copyright | 2007-07-10 | |
| dc.date.issued | 2007 | |
| dc.date.submitted | 2007-06-24 | |
| dc.identifier.citation | 英文部分
Andersen RM. Revisiting the Behavioral Model and access to medical care: does it matter? Journal of Health and Social Behavior 1995; 36:1-10. Anderson G, and Kerluke K. Distribution of prescription drug exposures in the elderly: description and implications. Journal of Clinical Epidemiology 1996; 49(8):929-935. Bardel A, Wallander MA, and Svärdsudd K. Reported current use of prescription drugs and some of its determinants among 35 to 65-year-old women in mid-Sweden: a population-based study. Journal of Clinical Epidemiology 2000; 53:637-643. Barat I, Andreasen F, and Damsgaard EMS. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000; 56:501-509. Bergman U, and Wiholm BE. Patient medication on admission to a medical clinic. European Journal of Clinical Pharmacology 1981; 20:185-191. Bjerrum L, Rosholm JU, Hallas J, and Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. European Journal of Clinical Pharamacology 1997; 53:7-11. Bjerrum L, Søgaard J, Hallas J, and Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. European Journal of Clinical Pharmacology 1998; 54:197-202. Bjerrum L, Søgaard J, Hallas J, and Kragstrup J. Polypharmacy in general practice: differences between practitioners. British Journal of General Practice 1999; 49:195-198. Balluz LS, Kieszak SM, Philen RM, and Mulinare J. Vitamin and mineral supplement use in the United States. Arch Fam Med 2000; 9:258-262. Burt CW. National trends in use of medications in office-based practice, 1985-1999. Health Affairs 2002; 21(4):206-214. Cheng SH, Chiang TL. The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment. JAMA 1997; 278:89-93. Colley CA, and Lucas LM. Polypharmacy: the cure becomes the disease. Journal of General Internal Medicine 1993; 8(5):278-83. Collin C, Wade DT, Davies S, and Horne V. The Barthel ADL Index: a reliability study. International Disability Studies 1988; 10:61-63. Davis AW, and Heavner JE. Polypharmacy, age, and scheduled surgery. Journal of Clinical Anesthesia 2002; 14:329-334. DH of England. National Service Framework. Medicines and Older People. Implementing medicines-related aspects of the NSF for Older People. 27 March 2001. DH of England. Statistical Bulletin, Prescriptions Dispensed in the Community Statistics for 1994 to 2004: England. Retrieved 2006 Aug 31 from http://www.ic.nhs.uk/pubs/ Delafuente JC. Perspectives on geriatric pharmacotherapy. Pharmacotherapy 1991; 11(3):222-224. Ebbesen J, Buajordet I, Erikssen J, Brors O, Hilberg T, Svaar H, and Sandvik L. Drug-related deaths in a department of internal medicine. Arch Intern Med 2001; 161(19): 2317-2323. Ennis KJ, and Reichard RA. Maximizing drug compliance in the elderly. Tips for staying on top of your patients' medication use. Postgrad.Med 1997; 102:211-3. Fincke BG, Snyder K, Cantillon C, Gaehde S, Standring P, Fiore L, Brophy M, and Gagnon D. Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiology and drug safety 2005; 14:121-128. Flodin NW. Micronutrient supplements: toxicity and drug interactions. Prog Food Nutr Sci 1990; 14:277-331. Francis SA, Barnett N, Denham M. Switching of prescription drugs to over-the-counter status: is it a good thing for the elderly? Drugs Aging 2005; 22:361-70. Friedman B, Jiang H, Elixhauser A, and Segal A. Hospital costs for adults with multiple chronic conditions. Medical Care Research and Review 2006; 63(3):327-346. Gupta S, Rappaport HM, and Bennett LT. Polypharmacy among nursing home geriatric Medicaid recipients. The Annals of Pharmacotherapy 1996; 30:946-950. Guralnik JM, and Simonsick EM. Physical disability in older Americans. Journal of Gerontology 1993; 48(suppl):3-10. Hanlon JT, Schmader KE, Ruby CM, and Weinberger M. Suboptimal prescribing in older inpatients and outpatients. Journal of the American Geriatrics Society 2001; 49(2):200-209. Helling DK, Lemke JH, Semla TP, Wallace RB, Lipson DP, and Cornoni-Huntley J. Medication use characteristics in the elderly: the Iowa 65+ Rural Health Study. JAGS 1987; 35:4-12. Hoffman C, Rice D, and Sung HY. Persons with chronic conditions: their prevalence and costs. JAMA 1996; 276(18):1473-1479. Huang WF, Hsiao FY, Tsai YW, Wen YW, and Shih YT. Cardiovascular events associated with long-term use of Celecoxib, Rofecoxib and Meloxicam in Taiwan. Drug Safety 2006; 29(3):261-272. Huang WF, Hsiao FY, Wen YW, and Tsai YW. Cardiovascular events associated with the use of fur nonselectie NSAIDs (Etodolac, Nabumetone, Ibuprofen, or Naproxen) versus a cyclooxygenase-2 inhibitor (Celecoxib): a population-based analysis in Taiwanese adults. Clinical Therapeutics 2006; 28(11):1-10. Huang WF, and Lai IC. Patterns of sleep-related medications prescribe to elderly otpatients with insomnia in Taiwan. Drugs & Aging 2005; 22(11):957-965. Huang WF, and Lai IC. Potentially inappropriate prescribing for insomnia in elderly outpatients in Taiwan. International Journal of Clinical Pharmacology and Therapeutics 2006; 44(7):335-342. Jaggar SF. Dangerous prescriptions for the elderly. Consumers' Research Magazine 1996; 79:22. Jameson JP, and VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. The Annals of Pharmacotherapy 2001; 35:835-840. Jones AB. Decreasing polypharmacy in clients most at risk. AACN Clinical Issues 1997; 8(4):627-634. Jörgensen T, Johansson S, Kennerfalk A, Wallander M, and Svärdsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. The Annals of Pharmacotherapy 2001; 35(9):1004-1009. Jörgensen T, Isacson D, and Thorslund M. Prescription drug use among ambulatory elderly in a Swedish municipality. The Annals of Pharmacotherapy 1993; 27:1120-1125. Joyce GF, Keeler EB, Shang B, and Goldman DP. The lifetime burden of chronic disease among the elderly. Health Affairs 2005; 24 Suppl 2:W5R18-29. Katz S, Ford AB, Moskowitq RW, Jackson BA, and Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185:914-919. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, and Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA 2002; 287:337-44. Kennerfalk A, Ruigómez A, Wallander MA, Wilhelmsen L, and Johansson S. Geriatric drug therapy and healthcare utilization in the United Kingdom. The Annals of Pharmacotherapy 2002; 36:797-803. Klaukka T, Mäkelä M, Sipilä J, and Martikainen J. Multiuse of medicines in Finland. Medical Care 1993; 31(5):445-50. Koh Y, Kutty FBM, and Li SC. Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study. Pharm World Sci 2003; 25(4):135-137. Koh NY, and Koo WH. Polypharmacy in palliative care: can it be reduced? Singapore Med J 2002; 43(6):279-283. Kohout FJ, Berkman LF, Evans DA, and Cornoni-Huntley J. Two shorter forms of the CES-D Depression Symptoms Index. Journal of Aging and Health 1993; 5(2):179-193. Kotzan L, Carroll NV, and Kotzan JA. Influence of age, sex, and race on prescription drug use among Georgia Medicaid recipients. American Journal of Hospital Pharmacy 1989; 46:287-290. Law R, and Chalmers C. Medicines and elderly people: a general practice survey. British Medical Journal 1976;6:565-568. Lawton MP, and Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9(3):179-86. Lin D, Mok H, and Yatham LN. Polytherapy in bipolar disorder. CNS Drugs 2006; 20(1):29-42. Lindley CM, Tully MP, Paramsothy V, and Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age & Ageing 1992; 21:294-300. Linjakumpu T, Hartkainen S, Klaukka T, Veijola J, Kivela S, and Isoaho R.. Use of medications and polypharmacy are increasing among the elderly. Journal of Clinical Epidemiology 2002; 55(8):809-817. Mamun K, Lien CTC, Goh-Tan CYE, and Ang WST. Polypharmacy and inappropriate medicaiton use in Singapore nursing homes. Annals Academy of Medicine 2004; 33(1):49-52. Meyer TJ, Van Kooten D, Marsh S, and Prochazka AV. Reduction of polypharmacy by feedback to clinicians. J Gen Internal Med 1991; 6:133-136. Millar WJ. Multiple medication use among seniors. Health Reports 1998; 9(4):11-17. Nguyen JK, Fours MM, Kotabe SE, and Lo E. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. The American Journal of Geriatric Pharmacotherapy 2006; 4(1):36-41. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. Journal of the American Geriatrics Society 1975; 23(10):433-41. Preskorn SH, Silkey B, Shah R, Neff M, Jones TL, Choi J, and Golbeck AL. Complexity of medication use in the Veterans Affairs Healthcare System: part I: outpatient use in relation to age and number of prescribers. Journal of Psychitric Practice 2005; 11(1):5-15. Quinn K, Baker MJ, and Evans B. A population-wide profile of prescription drug use in Saskatchewan, 1989. Can Med Assoc J 1992; 146(12):2177-2186. Radloff, LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1977; 1:385-401. Rosholm JU, Bjerrum L, Hallas J, Worm J, and Gram LF. Polypharmacy and the risk of drug-drug interactions among Danish elderly. A prescription database study. Danish Medical Bulletin 1998; 45(2):210-213. Sharkey JR, Browne B, Ory MG, and Wang S. Patterns of therapeutic prescription medication category use among community-dwelling homebound older adults. Pharmacoepidemiology and Drug Safety 2005; 14:715-723. Simons LA, Tett S, Simons J, Lauchlan R, McCallum J, Friedlander Y, and Powell I. Multiple medication use in the elderly. Use of prescription and non-prescription drugs in an Australian community setting. The Medical Journal of Australia 1992; 157:242-246. Stewart RB, Moore MT, May FE, Marks RG, and Hale WE. A longitudinal evaluation of drug use in an ambulatory elderly population. J Clin Epidemiol 1991; 44(12):1353-1359. Tamblyn RM, McLeod PJ, Abrahamowicz M, and Laprise, R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. Canadian Medical Association Journal 1996; 154(8):1177-1184. Thomas HF, Sweetnam PM, Janchawee BJ, and Luscombe. Polypharmacy among older men in South Wales. European Journal of Clinical Pharmacology 1999; 55:411-415. Tsuji-Hayashi Y, Fukuhara S, Green J, and Kurokawa K. Use of prescribed drugs among older people in Japan: association with not having a regular physician. American Geriatrics Society 1999; 47:1425-1429. Vedsted P, Sørensen HT, DMSc, and Mortensen JT. Drug prescription for adult frequent attenders in Danish general practice: a population-based study. Pharmacoepidemiology and Drug Safety 2004; 13:717-724. Veehof LJ, and Schuling J. Polypharmacy in the elderly with chronic diseases: conflicting interests. Ned.Tijdschr.Geneeskd 1997; 141:177-9. Veehof L, Stewart R, Haaijer-Ruskamp F, and Meyboom-de Jong B. The development of polypharmacy: A longitudinal study. Family Practice 2000; 17(3):261-267. Veehof LJG, Stewart RE, Meyboom-de Jong B, and Haaijer-Ruskamp FM. Adverse drug reactions and polypharmacy in the elderly in general practice. European Journal of Clinical Pharmacology 1999; 55(7):533–536. Viola R, Csukonyi K, Doró P, Janka Z, and Soós G. Reasons for polypharmacy among psychiatric patients. Pharmacy world & science 2004; 26:143-147. Wold RS, Lopez ST, Yau CL, Butler LM, Pareo-Tubbeh SL, Waters DL, Garry PJ, and Baumgartner RN. Increasing trends in elderly person’s use of nonvitamin, nonmineral dietary supplements and concurrent use of medicaitons. Journal of the American Dietetic Association 2005; 105:54-63. Wolff JL, Starfield B, and Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002; 162(11):2269-2276. World Health Organization, Collaborating Centre for Drug Statistics Methodology, Retrieved August 28, 2006, from http://www.whocc.no/ World Health Organization, Regional Office for Europe, Copenhagen. Drugs for the elderly. 1985. (as cited in Kennerfalk, 2002) 中文部分 行政院衛生署家庭計畫研究所:民國八十五年台灣地區中老年保健與生涯規劃調查報告,民88年。 高淑真,李玉春,黃文鴻,與李龍騰:全民健保糖尿病門診問題處方之分析—以北台灣為中心之研究。台灣衛誌,2006,卷25期1,頁58-64。 郭巧儀:多醫就診者之醫療利用及其影響因素。國立陽明大學醫務管理研究所碩士論文,2004。 許良因:影響台灣成人自服西藥的因素。國立臺灣大學公共衛生學研究所碩士論文,1998。 陳育群:利用關聯規則探討醫學中心門診病患試醫行為。國立陽明大學衛生資訊與決策研究所碩士論文,2003。 陳師瑩,林佳蓉,高美丁,杭極敏,潘文涵:台灣地區老人營養健康狀況調查1999-2000:65歲以上國人服用膳食補充品的狀況與原因,行政院衛生署,91-118,2004。 梁煙純:我國多重慢性病患盛行率及醫療利用分析。國立陽明大學醫務管理研究所碩士論文,2004。 黃士甄:台灣地區polypharmacy之流行病學研究。高雄醫學大學藥學研究所碩士論文,2003。 黃繼慶:社會支持系統對社區老人心理健康的影響。國立臺灣大學公共衛生研究所碩士論文,1994。 謝博生:迎向21世紀的醫療體系。台灣醫學,2001,4卷1期。 中央健康保險局網站,下載檔案自 http://www.nhi.gov.tw/webdata/webdata.asp?menu=1&menu_id=26&webdata_id=940,瀏覽日期2007.05.20。 中央健康保險局網站,下載檔案自 http://www.nhi.gov.tw/webdata/webdata.asp?menu=1&menu_id=7&webdata_id=789 ,瀏覽日期2006.10.30。 中央健康保險局支出面資料使用字典,page E-6-0007-001~ E-6-0007-003。 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30673 | - |
| dc.description.abstract | 本研究之主要目的為呈現台灣失能老人多重用藥之盛行率,並探討其相關因素。研究樣本來自「全國長期照護需要評估」計畫資料中65歲以上之失能樣本,共11,788人,由調查檔中得到樣本之性別、年齡、教育程度、籍貫、心理健康、身體功能狀況、長期照顧模式等資訊,再連結其健保檔中的門診處方及治療明細檔(CD檔)及門診處方醫令明細檔(OO檔),以取得樣本在研究期間(2001年7月至2002年6月)的西醫門診就醫及用藥資訊共同分析。
台灣失能老人多重用藥(最大單日用藥種數在5種以上)的盛行率為81.0%,重度多重用藥(最大單日用藥種數在10種以上)的盛行率為38.1%。有將近三分之一的人(32.5%)有半年以上的時間,每天用藥5種以上;多重用藥天數平均值為122.5天,中位數為61天。 邏輯斯迴歸分析發現,發生多重用藥機會較高者為:年齡小於85歲、需部分負擔者、身體功能狀況為重度依賴或中度依賴者、共病症數目較多者及就醫傾向不固定(OR值7.147,95%CI 6.043-8.452)或中等者(OR值2.434,95%CI 2.122-2.792)。 發生多重用藥半年以上機會較高者為:年齡小於85歲、女性、外省人或福佬人、教育程度較高、有偶者、城鄉別在直轄市或省轄市者、需部分負擔者、居家且有請全職看護者、身體功能狀況之依賴程度較高者、共病症數目較多者、傾向至醫院就醫者及就醫傾向不固定(OR值1.696,95%CI為1.503-1.913)或中等者(OR值1.256,95%CI為1.102-1.430)。 在控制身體狀況之後,無固定就醫者發生多重用藥的機會非常的高,如何改進以減少多重用藥,進而降低因多重用藥而帶來的風險,是醫療體系制度改革應重視的議題。 | zh_TW |
| dc.description.abstract | The objectives of this study are to determine the prevalence and correlates of polypharmacy among disabled elderly in Taiwan. Eleven thousand, seven hundred and eighty-eight disabled people aged 65 years and above from the ‘Evaluation of Taiwan National Requirements for Long-Term Care’ were enrolled in the current study. Subject identification information was linked to the National Health Insurance claim database to obtain all prescription data from western medical ambulatory visits between July 2001 and June 2002.
The prevalence of polypharmacy (defined as prescriptions of >=5 medications on the day of maximum numbers of medications prescribed during the study period) and major polypharmacy (>=10 medications) among disabled Taiwanese elders were 81.0% and 38.1%, respectively. Almost one-third (32.5%) of people were exposed to polypharmacy for more than 181 days during the study year. The average number of days of exposure was 122.5 days, and the median was 61 days. The tendency to usual healthcare sources was the strongest correlates of polypharmacy in multivariate logistic regression models. Compared to those with high tendency to usual healthcare sources, those with low tendency (OR= 7.147; 95%CI, 6.043 - 8.452) and those with intermediate tendency (OR=2.434; 95%CI, 2.122 - 2.792) were more likely to be exposed to polypharmacy. Other significant correlates of polypharmacy included younger age, requiring co-payment, and poor physical functioning. Significant correlates for exposure to polypharmacy for more than 181 days from multivariate were being under 85 years old, being female, being Mainlanders or Islanders, having higher education, being married, living in big cities, requiring co-payment, dwelling in community with a fulltime caregiver, being physically dependent, having more comorbidities, tending to seek medical advice from doctors in hospitals, and having low or intermediate tendency to usual healthcare sources. The prevalence of polypharmacy was extremely high in disabled Taiwanese elders. Lack of usual healthcare providers was one of the strongest correlates of polypharmacy. Our results suggested that policies to encourage elders to visit fewer healthcare providers may decrease the prevalence of polypharmacy and associated adverse outcomes. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T02:11:55Z (GMT). No. of bitstreams: 1 ntu-96-R94845110-1.pdf: 597357 bytes, checksum: c42a5ab147b23347f15d401da6883ec2 (MD5) Previous issue date: 2007 | en |
| dc.description.tableofcontents | 誌 謝 i
摘 要 ii Abstract iii 目錄 iv 表目錄 v 圖目錄 v 附錄 v 第一章 前言 1 第二章 文獻探討 5 第一節 多重用藥的定義 5 第二節 多重用藥的研究方法 6 第三節 多重用藥對於老人的影響 7 第四節 老人多重用藥的測量方法與盛行狀況 8 第五節 使用藥物種類 13 第六節 影響多重用藥之相關因素 16 第七節 Andersen model醫療服務利用行為模式 21 第三章 研究方法 25 第一節 研究架構 25 第二節 研究假說 27 第三節 研究材料 28 第四節 研究變項及操作型定義 29 (一)依變項 29 (二)自變項 32 第五節 資料處理及分析方法 35 第四章 研究結果 36 第一節 樣本特質 36 第二節 多重用藥狀況描述 38 第三節 多重用藥與影響因素之雙變項分析 39 (一)用藥種數與影響因素之雙變項分析 39 (二)多重用藥天數與影響因素之雙變項分析 42 第四節 多重用藥與影響因素之多變項分析 47 (一)用藥種數與影響因素之多變項分析 47 (二)多重用藥天數與影響因素之多變項分析 48 第五節 多變項分析之綜合整理 50 第五章 結論與討論 51 第一節 研究結果重點及討論 51 第二節 研究限制 57 第三節 政策意涵 59 第四節 未來研究建議 60 參考文獻 100 表4.1 基本特性分布:前傾因素 61 表4.2 基本特性分布:使能因素 62 表4.3-1 基本特性分布:需要因素-有各種疾病的人數及百分比 63 表4.3-2 基本特性分布:需要因素 64 表4.4 基本特性分布:其他因素 65 表4.5 最大單日用藥種數分布 66 表4.6 台灣65歲以上失能人口用藥種數(%) 66 表4.7 多重用藥(使用5種以上)天數分布 67 表4.8 總樣本與多重用藥老人最常使用的藥理分類排名 68 表4.9-1 總樣本與多重用藥老人的慢性疾病排名 69 表4.9-2 總樣本與多重用藥老人的慢性病類數比較 70 表4.10 最大單日用藥種數三分組與前傾因素之分布 71 表4.11 最大單日用藥種數三分組與使能因素之分布 72 表4.12 最大單日用藥種數三分組與需要因素之分布 73 表4.13 最大單日用藥種數三分組與其他因素之分布 74 表4.14 多重用藥(5種以上)天數四分組與前傾因素之雙變項分析 75 表4.15 多重用藥(5種以上)天數四分組與使能因素之雙變項分析 76 表4.16 多重用藥(5種以上)天數四分組與需要因素之雙變項分析 77 表4.17 多重用藥(5種以上)天數四分組與其他因素之雙變項分析 78 表4.18 邏輯斯迴歸之參考組說明 79 表4.19 多重用藥之邏輯斯迴歸分析(參考組=未多重用藥,即0-4種) 80 表4.20 多重用藥(5種以上)天數二分組之邏輯斯迴歸分析(參考組=1-90天) 81 表4.21 邏輯斯迴歸分析結果綜合整理 82 圖2.1 第一階段醫療服務利用行為模式 21 圖2.2 第二階段醫療服務利用行為模式 23 圖2.3 第三階段醫療服務利用行為模式 23 圖2.4 第四階段醫療服務利用行為模式 24 圖4.1 最大單日用藥種數 66 圖4.2 多重用藥(使用5種以上)之天數 67 附錄一、polypharmacy的定義及測量 83 附錄二、多重用藥盛行率比較 99 | |
| dc.language.iso | zh-TW | |
| dc.subject | 多重用藥 | zh_TW |
| dc.subject | 失能老人 | zh_TW |
| dc.subject | 台灣 | zh_TW |
| dc.subject | disable elderly | en |
| dc.subject | Taiwan | en |
| dc.subject | polypharmacy | en |
| dc.title | 台灣失能老人多重用藥之研究 | zh_TW |
| dc.title | Polypharmacy among Disabled Elderly in Taiwan | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 95-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 黃文鴻,詹鼎正 | |
| dc.subject.keyword | 多重用藥,失能老人,台灣, | zh_TW |
| dc.subject.keyword | polypharmacy,disable elderly,Taiwan, | en |
| dc.relation.page | 109 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2007-06-25 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 衛生政策與管理研究所 | zh_TW |
| 顯示於系所單位: | 健康政策與管理研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-96-1.pdf 未授權公開取用 | 583.36 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
